Sedation and Neuromuscular Blockade in Patients With Acute Respiratory Failure

Luer, Jill M.
October 2002
Critical Care Nurse;Oct2002, Vol. 22 Issue 5, p70
Academic Journal
Reveals important complications of neuromuscular blockade in patients with acute respiratory failure. Discussion on when are sedative, analgesic or neuromuscular blocking agents indicated in critically ill patients with respiratory disease; Factors that must be considered when selecting a specific agent.


Related Articles

  • Bacteria-Specific Neutrophil Dysfunction Associated with Interferon-Stimulated Gene Expression in the Acute Respiratory Distress Syndrome. Malcolm, Kenneth C.; Kret, Jennifer E.; Young, Robert L.; Poch, Katie R.; Caceres, Silvia M.; Douglas, Ivor S.; Coldren, Chris D.; Burnham, Ellen L.; Moss, Marc; Nick, Jerry A. // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Acute respiratory distress syndrome (ARDS) is a poorly understood condition with greater than 30% mortality. Massive recruitment of neutrophils to the lung occurs in the initial stages of the ARDS. Significant variability in the severity and duration of ARDS-associated pulmonary inflammation...

  • A protocol for a systematic literature review: comparing the impact of seasonal and meteorological parameters on acute respiratory infections in Indigenous and non-Indigenous peoples. Bishop-Williams, Katherine E.; Sargeant, Jan M.; Berrang-Ford, Lea; Edge, Victoria L.; Cunsolo, Ashlee; Harper, Sherilee L. // Systematic Reviews;1/26/2017, Vol. 6, p1 

    Background: Acute respiratory infections (ARI) are a leading cause of morbidity and mortality globally, and are often linked to seasonal and/or meteorological conditions. Globally, Indigenous peoples may experience a different burden of ARI compared to non-Indigenous peoples. This protocol...

  • ECMO in adults for severe respiratory failure finally comes of age: just in time?  // Thorax;Mar2010, Vol. 65 Issue 3, p194 

    The authors reflect on the study conducted by G. J. Peek and colleagues regarding the performance of extracorporeal membrane oxygenation (ECMO) in patients suffering from severe acute respiratory failure (ARF). The authors say that the study was able to demonstrate that ECMO can lead those with...

  • A Novel Experimental Model of Acute Respiratory Distress Syndrome in Pig. OTÁHAL, M.; MLČEK, M.; VÍTKOVÁ, I.; KITTNAR, O. // Physiological Research;2016 Supplement5, Vol. 65, pS643 

    Acute respiratory distress syndrome (ARDS) is severe medical condition occurring in critically ill patients and with mortality of 33-52% is one of the leading causes of death in critically ill patients. To better understand pathophysiology of ARDS and to verify novel therapeutical approaches a...

  • Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Guay, J.; Grenier, Y.; Varin, F. // Clinical Pharmacokinetics;1998, Vol. 34 Issue 6, p483 

    Despite an increased in bodyweight, plasma volume by 45% and blood volume by 35% that might influence the volume of distribution of polar drugs, the apparent volume of distribution at steady state (Vss), volume of distribution (Vd) and the apparent volume of the central compartment (Vc) of...

  • Clinical Pharmacokinetics of the Newer Neuromuscular Blocking Drugs. Paul, D.; Atherton, L.; Hunter, J.M. // Clinical Pharmacokinetics;1999, Vol. 36 Issue 3, p169 

    The pharmacokinetics of 6 new neuromuscular blocking drugs are described. These are the aminosteroids pipecuronium bromide, rocuronium bromide and rapacuronium bromide (ORG-9487) and the benzylisoquinolinium diesters doxacurium chloride, mivacurium chloride and cisatracurium besilate. In healthy...

  • Rapacuronium Bromide: A Review of its Use in Anaesthetic Practice. Onrust, S.V.; Foster, R.H. // Drugs;Nov1999, Vol. 58 Issue 5, p887 

    Rapacuronium bromide (rapacuronium) is an aminosteroid, nondepolarising neuromuscular blocking agent (NMBA). At the recommended dose for endotracheal intubation (1.5 mg/kg), an intravenous bolus of rapacuronium has a rapid onset (≈1.2 to 1.8 minutes) and short duration of action (10.2 to...

  • Spatial Effects in Modeling Pharmacokinetics of Rapid Action Drugs. Lafrance, Patrick; Lemaire, Vincent; Varin, France; Donati, François; Bélair, Jacques; Nekka, Fahima // Bulletin of Mathematical Biology;May2002, Vol. 64 Issue 3, p483 

    We develop a model to describe the time course of plasma concentration of neuromuscular blocking agents used as anesthetics during surgery. This model, which overcomes the limitations of the classical compartment models routinely used in pharmacokinetics, incorporates spatial effects due to...

  • Reversal of neuromuscular block.  // BJA: The British Journal of Anaesthesia;Oct2009, Vol. 103 Issue 4, p622 

    A correction to the article "Reversal of Neuromuscular Block" that was published in a previous issue is presented.

  • When paralysis is intentional. Reichenbach, Sheryl Lewis; Moore, Kathleen // RN;Jun95, Vol. 58 Issue 6, p42 

    Discusses the increasing use of neuromuscular blockers in intensive care. Deliberate paralysis of skeletal muscles while sparing cardiac and smooth muscle; Positive effects of paralysis; Factors for the selection of blockers to use on specific patients; Include vecuronium, atracurium and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics